Bioenvelop Div Squire Pharmaceuticals
BioEnvelop™ differentiates itself with its Thinsol Technology. Thinsol™ is a water-based, enzymatically-digested carboxymethylcellulose (CMC-enz) film that is suitable for the rapid delivery of pharmaceutical and nutraceutical active ingredients. BioEnvelop™ has submitted a patent application for this novel oral ingestible film composition delivery system, Thinsol™.
Thinsol™ may offer significant advantages over current edible film technologies. BioEnvelop's™ research has determined that use of the Thinsol™ delivery technology allows for the development of products that others may not be able to formulate in a film strip format, such as products that are heat-sensitive and those that require high drug loads on each strip.
Contact Bioenvelop Div Squire Pharmaceuticals
Email - none provided
Print this page